DSTU2

This page is part of the FHIR Specification (v1.0.2: DSTU 2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions

F.21.1.5 StructureDefinition: QICore-Medication - Mappings

Mappings for the qicore-medication Profile.

F.21.1 Mappings for Quality Improvement Domain Analysis Model (http://www.hl7.org/implement/standards/product_brief.cfm?product_id=378)

QICore-Medication
MedicationQICore-Medication
   id
   meta
   implicitRules
   language
   text
   contained
   extension
   modifierExtension
   code
   isBrand
   manufacturer
   product
      id
      extension
      modifierExtension
      form
      ingredient
         id
         extension
         extensionMedication.product.ingredient.isActiveIngredientNot in QIDAM, but added because it was determined to be important for drug-allergy checking. For example, if the patient is allergic to Depakote (a trade name, and includes blue dye as an inactive ingredient), then when patient is prescribed warfarin, it shoots out a drug-allergy alert because warfarin also contains blue dye. Providers hate this. We recently overcame this problem by having the drug-allergy alert interaction settings only check for allergies to active ingredients.
         modifierExtension
         item
         amount
      batch
         id
         extension
         modifierExtension
         lotNumber
         expirationDate
   package
      id
      extension
      modifierExtension
      container
      content
         id
         extension
         modifierExtension
         item
         amount